183490.KQ
Enzychem Lifesciences Corporation
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 990.00
−2.65%Margins
Gross margin
4.7%
EBITDA margin
-22.3%
EBIT margin
-27.0%
Net margin
-26.8%
FCF margin
-17.4%
-13.2%
Return on equity
-12.2%
Return on assets
-12.8%
Return on invested capital
0.43x
Asset turnover
-KRW 11.0B
Cash from operations
KRW 1.1K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025